StockData
GSACOTCPharmaceutical PreparationsFiscal year ends December 31

GELSTAT CORP

Last filing: 10-K/A on Nov 21, 2012
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

About Gelstat

Pharmaceutical Preparations, SIC 2834

GelStat Corporation is a consumer healthcare company focused on developing and commercializing over-the-counter and non-prescription healthcare products. Its primary commercial product is GelStat Migraine, a patented sublingually administered homeopathic drug designed to provide acute relief from migraine and migraine-like headache pain and symptoms. The company is also developing GelStat Sleep, an orally dispersible dietary supplement tablet formulated without antihistamines to serve as a sleep aid. GelStat offers its products directly to consumers primarily through its corporate website, alongside distribution via a limited selection of retailers.

The company operates in the United States and evaluates opportunities to expand internationally. It maintains an executive office in Palm City, Florida, and a warehouse and distribution facility in Stuart, Florida. GelStat relies on third-party vendors for operations, outsourcing all of its manufacturing and packaging activities. At the time of the filing, the company reported having zero employees.

Summary of the business section of Gelstat's latest annual report, written by StockData.

Company profile

Company

Legal name
GELSTAT CORP
Founded
1991
Headquarters
Miami, FL
Address
333 Se 2nd Avenue, Suite 2000 33131
Phone
(772) 212-1368
Employees
44, Dec 31, 2008
Industry
Pharmaceutical Preparations
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
GSAC
Exchange
OTC
IPO date
Feb 9, 1996
Stock splits
3-for-2, Sep 1, 2004; 2-for-1, Oct 21, 2003
SEC CIK
890725
EIN
90-0075732

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Gelstat's leadership is listed in its proxy statement, last filed Jul 12, 2004.

Employees

Headcount reported in annual reports

“The following table sets forth the directors, officers, and significant employees of the Company, their ages and positions with the … Gerald N. Kieft 44”

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 16, 2009DeregistrationTermination of SEC registration (Form 15)
Mar 31, 2006Late filingNotification of late filing
Nov 16, 2005Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 11, 2005Late filingNotification of late filing
Mar 30, 2005Late filingNotification of late filing
Aug 14, 2003Late filingNotification of late filing
Jul 15, 2003Name changeName changed from DEVELOPED TECHNOLOGY RESOURCE INC to GELSTAT CORP
Mar 29, 2002Late filingNotification of late filing
Apr 2, 2001Late filingNotification of late filing
Nov 14, 2000Late filingNotification of late filing
Aug 16, 2000Late filingNotification of late filing
May 16, 2000Late filingNotification of late filing
Mar 28, 2000Late filingNotification of late filing
May 17, 1999Late filingNotification of late filing
Apr 1, 1999Late filingNotification of late filing
Jun 15, 1998Late filingNotification of late filing
Jan 30, 1998Late filingNotification of late filing
Sep 16, 1997Late filingNotification of late filing
Jun 17, 1997Late filingNotification of late filing
Mar 18, 1997Late filingNotification of late filing